Skip to content

A prospective study of the efficacy of 5G-cloud technology support platform used in implantable cardiac resynchronization therapy follow-up

A prospective study of the efficacy of 5G-cloud technology support platform used in implantable cardiac resynchronization therapy follow-up

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059172
Enrollment
Unknown
Registered
2022-04-26
Start date
2022-09-01
Completion date
Unknown
Last updated
2024-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

Outpatient follow-up group:Nil
Remote follow-up group:Nil

Sponsors

The First Affiliated Hospital of Naval Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Indications for CRTP/CRTD implantation: Heart failure patients with grade II to IV cardiac function after adequate anti-heart failure drug treatment, EF=55mm, complete left bundle branch block or indoor block (QRS>=130ms); 2. Participate in clinical trials voluntarily and sign informed consent; 3. Physical examination, laboratory examination, electrocardiogram and color doppler ultrasound should be performed before the test.

Exclusion criteria

Exclusion criteria: 1. Patients with endless ventricular tachycardia or ventricular fibrillation; 2. Have unstable heart disease, such as acute coronary syndrome; 3. Expected survival <1 year; 4. Clear medical history or other significant diseases of the nervous and psychiatric system, kidney, liver, digestive system, respiratory system, metabolic system and blood system; 5. The researchers considered it inappropriate to participate in the experiment.

Design outcomes

Primary

MeasureTime frame
cardiovascular complex endpoints were hospitalization for heart failure, emergency department visits for cardiac reasons, and non-planned outpatient visits for equipment-related problems within 1 year;

Secondary

MeasureTime frame
health-related quality of life;cost-effectiveness;patient satisfaction with their remote follow-up care;pacemaker and lead malfunctions were detected during follow-up;

Countries

China

Contacts

Public ContactGuo Zhifu
guozhifu@126.com+86 13918459432

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026